Eloxx Pharmaceuticals, Inc.
ELOX · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36,065 | -$66,727 | -$34,577 | -$50,874 |
| Dep. & Amort. | $695 | $960 | $571 | $559 |
| Deferred Tax | $81 | -$456 | $15 | -$303 |
| Stock-Based Comp. | $3,021 | $9,167 | $8,666 | $11,336 |
| Change in WC | -$118 | -$32 | -$3,404 | -$644 |
| Other Non-Cash | $541 | $22,087 | $563 | $535 |
| Operating Cash Flow | -$31,845 | -$35,001 | -$28,166 | -$39,391 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$66 | -$89 | $0 | -$40 |
| Net Acquisitions | $0 | $2,145 | $0 | $2 |
| Inv. Purchases | $0 | $0 | $0 | -$67,214 |
| Inv. Sales/Matur. | $0 | $0 | $33,750 | $33,750 |
| Other Inv. Act. | $0 | $0 | $42 | -$22 |
| Investing Cash Flow | -$66 | $2,056 | $33,792 | -$33,524 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $491 | -$3,786 | $15,000 |
| Stock Issued | $0 | $47,718 | $0 | $32,882 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8,812 | $2,579 | $348 | -$1,082 |
| Financing Cash Flow | $8,812 | $50,788 | -$3,438 | $46,800 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$23,099 | $17,843 | $2,188 | -$26,115 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $42,567 | $24,724 | $22,536 | $48,651 |
| End Cash | $19,468 | $42,567 | $24,724 | $22,536 |
| Free Cash Flow | -$31,911 | -$35,090 | -$28,166 | -$39,431 |